Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 118.15 USD -1.91% Market Closed
Market Cap: 6.6B USD

Intrinsic Value

The intrinsic value of one RGEN stock under the Base Case scenario is 70.85 USD. Compared to the current market price of 118.15 USD, Repligen Corp is Overvalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RGEN Intrinsic Value
70.85 USD
Overvaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Repligen Corp

Valuation History Unavailable

Historical valuation for RGEN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Repligen Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Repligen Corp

Current Assets 1B
Cash & Short-Term Investments 697.2m
Receivables 147.4m
Other Current Assets 187.8m
Non-Current Assets 1.8B
PP&E 325.2m
Intangibles 1.5B
Other Non-Current Assets 2.9m
Efficiency

Free Cash Flow Analysis
Repligen Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Repligen Corp

Revenue
803.6m USD
Cost of Revenue
-393.6m USD
Gross Profit
410m USD
Operating Expenses
-389.4m USD
Operating Income
20.6m USD
Other Expenses
-40.3m USD
Net Income
-19.7m USD
Fundamental Scores

RGEN Profitability Score
Profitability Due Diligence

Repligen Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
51/100
Profitability
Score

Repligen Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

RGEN Solvency Score
Solvency Due Diligence

Repligen Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
68/100
Solvency
Score

Repligen Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 187.27 USD with a low forecast of 141.4 USD and a high forecast of 231 USD.

Lowest
Price Target
141.4 USD
20% Upside
Average
Price Target
187.27 USD
59% Upside
Highest
Price Target
231 USD
96% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Repligen Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for RGEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RGEN Insider Trading
Buy and sell transactions by insiders

RGEN News

Other Videos
What is the Intrinsic Value of one RGEN stock?

The intrinsic value of one RGEN stock under the Base Case scenario is 70.85 USD.

Is RGEN stock undervalued or overvalued?

Compared to the current market price of 118.15 USD, Repligen Corp is Overvalued by 40%.

Back to Top